The latest iteration of a US Food and Drug Administration draft guidance on use of electronic systems and records in clinical investigations includes recommendations on preparing for FDA inspections, considerations for real-world data and digital health technologies, and the need for service level agreements between sponsors and IT providers.
The draft guidance, “Electronic Systems, Electronic Records and Electronic Signatures on Clinical Investigations Questions and Answers,” is intended to align a September 2003 guidance on the scope and application...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?